Evaxion A/S

EVAX

US29970R3030

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 00:00:00 14/03/2026 +04			5-day change	1st Jan Change
4.260 ^USD	+1.91%		+32.30%	-10.69%

03-13	European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading	MT
03-12	European Equities Traded in US as ADRs Slump in Thursday Trading	MT

Ladenburg Thalmann Upgrades Evaxion Biotech to Buy From Neutral, Price Target is $8

Published on 04/02/2024 at 07:45 pm +04 - Modified on 04/02/2024 at 07:46 pm +04

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Evaxion A/S

03-13	European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading	MT
03-12	European Equities Traded in US as ADRs Slump in Thursday Trading	MT
03-10	European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading	MT
03-09	European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading	MT
03-06	European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading; Down 5% for Week	MT
03-06	Evaxion A/S, 2025 Earnings Call, Mar 06, 2026
03-05	Evaxion A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
03-05	European Equities Traded in the US as American Depositary Receipts Slide in Thursday Trading	MT
03-04	European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	MT
03-02	European Equities Traded in the US as American Depositary Receipts Tumble in Monday Trading	MT
02-25	European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	MT
02-24	European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading	MT
02-19	European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	MT
02-17	European Equities Traded in the US as American Depositary Receipts Track Slightly Lower in Tuesday Trading	MT
02-13	European Equities Traded in the US as American Depositary Receipts Decline Friday	MT

Evaxion Biotech A/S is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

Employees

Sector

Biotechnology & Medical Research

Calendar

05-07 - Earnings release - Q1 2026

More about the company